Literature DB >> 3740218

Pulmonary inflammation in autoimmune MRL/Mp-lpr/lpr mice. Histopathology and bronchoalveolar lavage evaluation.

E V Sunderrajan, W N McKenzie, T R Lieske, J L Kavanaugh, S R Braun, S E Walker.   

Abstract

Early detection of lupus pneumonitis is difficult because it requires lung biopsy. The authors describe here in detail the age-related histologic changes in pulmonary inflammation, the age-related changes in bronchoalveolar lavage (BAL), and the effect of cyclophosphamide (8 mg/kg) on pulmonary inflammation and bronchoalveolar lavage in MRL/Mp-lpr/lpr mouse, an animal model of systemic lupus erythematosus. To assess the evolution of pulmonary inflammation and response to cyclophosphamide therapy, they compared the age-related progression of pulmonary inflammation with sequential changes in BAL cell populations in this autoimmune mouse model. A striking similarity was noted between age-related changes in pulmonary inflammation and lymphocyte counts in BAL. A trend to reduction in histologic evidence of inflammation was reflected by lymphocytes in BAL in cyclophosphamide-treated (8 mg/kg/day) males but not in females. There was a striking sex-related difference in that the histologic evidence of pulmonary inflammation and bronchoalveolar lavage lymphocyte count in cyclophosphamide-treated males was significantly lower than cyclophosphamide-treated females of the same age.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3740218      PMCID: PMC1888295     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  17 in total

Review 1.  Pulmonary involvement in the collagen vascular diseases.

Authors:  G W Hunninghake; A S Fauci
Journal:  Am Rev Respir Dis       Date:  1979-03

2.  Analysis of airspace and interstitial mononuclear cell populations in human diffuse interstitial lung disease.

Authors:  G S Davis; A R Brody; J E Craighead
Journal:  Am Rev Respir Dis       Date:  1978-07

3.  Pulmonary alterations in systemic lupus erythematosus.

Authors:  M Gross; J R Esterly; R H Earle
Journal:  Am Rev Respir Dis       Date:  1972-04

4.  Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis.

Authors:  R A Matthay; M I Schwarz; T L Petty; R E Stanford; R C Gupta; S A Sahn; J C Steigerwald
Journal:  Medicine (Baltimore)       Date:  1975-09       Impact factor: 1.889

5.  Bronchoalveolar lavage in interstitial lung disease.

Authors:  S E Weinberger; J A Kelman; N A Elson; R C Young; H Y Reynolds; J D Fulmer; R G Crystal
Journal:  Ann Intern Med       Date:  1978-10       Impact factor: 25.391

6.  Flow cytometry analysis of T cells and continuous T-cell lines from autoimmune MRL/l mice.

Authors:  D E Lewis; J V Giorgi; N L Warner
Journal:  Nature       Date:  1981-01-22       Impact factor: 49.962

7.  The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients.

Authors:  H M Haupt; G W Moore; G M Hutchins
Journal:  Am J Med       Date:  1981-11       Impact factor: 4.965

8.  The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.

Authors:  E S REYNOLDS
Journal:  J Cell Biol       Date:  1963-04       Impact factor: 10.539

9.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

10.  Distribution of lymphocytes identified by surface markers in murine strains with systemic lupus erythematosus-like syndromes.

Authors:  A N Theofilopoulos; R A Eisenberg; M Bourdon; J S Crowell; F J Dixon
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307

View more
  11 in total

1.  Intercellular adhesion molecule-1 deficiency prolongs survival and protects against the development of pulmonary inflammation during murine lupus.

Authors:  C M Lloyd; J A Gonzalo; D J Salant; J Just; J C Gutierrez-Ramos
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  ROCK and Rho: Promising therapeutic targets to ameliorate pulmonary fibrosis.

Authors:  David W H Riches; Donald S Backos; Elizabeth F Redente
Journal:  Am J Pathol       Date:  2015-02-14       Impact factor: 4.307

3.  IRF4 deficiency abrogates lupus nephritis despite enhancing systemic cytokine production.

Authors:  Maciej Lech; Marc Weidenbusch; Onkar P Kulkarni; Mi Ryu; Murthy Narayana Darisipudi; Heni Eka Susanti; Hans-Willi Mittruecker; Tak W Mak; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2011-07-08       Impact factor: 10.121

4.  Comparative analysis of mediastinal fat-associated lymphoid cluster development and lung cellular infiltration in murine autoimmune disease models and the corresponding normal control strains.

Authors:  Yaser Hosny Ali Elewa; Osamu Ichii; Yasuhiro Kon
Journal:  Immunology       Date:  2015-11-16       Impact factor: 7.397

5.  A Skint6 allele potentially contributes to mouse lupus.

Authors:  Z Xu; J Xu; J Ju; L Morel
Journal:  Genes Immun       Date:  2017-05-11       Impact factor: 2.676

6.  Lung lymphocyte elimination by apoptosis in the murine response to intratracheal particulate antigen.

Authors:  A M Milik; V A Buechner-Maxwell; J Sonstein; S Kim; G D Seitzman; T F Beals; J L Curtis
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

7.  Use of bronchoalveolar lavage to compare local pulmonary immunity with the systemic immune response of Toxocara canis-infected mice.

Authors:  S G Kayes; R E Jones; P E Omholt
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

8.  Sex hormones modulate the response of pulmonary perivascular inflammation to cyclophosphamide therapy in MRL/MpJ-lpr/lpr mice.

Authors:  W N McKenzie; E V Sunderrajan; J L Kavanaugh; S Braun; L Ansbacher; S E Walker
Journal:  Am J Pathol       Date:  1988-06       Impact factor: 4.307

9.  Lack of the long pentraxin PTX3 promotes autoimmune lung disease but not glomerulonephritis in murine systemic lupus erythematosus.

Authors:  Maciej Lech; Christoph Römmele; Onkar P Kulkarni; Heni Eka Susanti; Adriana Migliorini; Cecilia Garlanda; Alberto Mantovani; Hans-Joachim Anders
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

10.  Therapy for pneumonitis and sialadenitis by accumulation of CCR2-expressing CD4+CD25+ regulatory T cells in MRL/lpr mice.

Authors:  Hitoshi Hasegawa; Atsushi Inoue; Masatake Muraoka; Jun Yamanouchi; Tatsuhiko Miyazaki; Masaki Yasukawa
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.